Halberd Corp
OTC:HALB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dur Hospitality Company SJSC
SAU:4010
|
SA |
|
Ecora Resources PLC
TSX:ECOR
|
UK |
Halberd Corp
Total Equity
Halberd Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Halberd Corp
OTC:HALB
|
Total Equity
-$207.1k
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Equity
$8.7B
|
CAGR 3-Years
33%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-11%
|
|
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
Total Equity
$789.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Incyte Corp
NASDAQ:INCY
|
Total Equity
$5.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
15%
|
CAGR 10-Years
41%
|
|
|
United Therapeutics Corp
NASDAQ:UTHR
|
Total Equity
$7.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
|
Moderna Inc
NASDAQ:MRNA
|
Total Equity
$8.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Halberd Corp
Glance View
Halberd Corp. is a development stage company, researches and develops antibodies and devices for the prevention, detection, and treatment of Covid-19 through laboratory, hospital, and clinical trials. The company is headquartered in Jackson Center, Pennsylvania. The company went IPO on 2009-06-12. The firm is a research-based company that intends to discover and develop medical treatments for a range of diseases. The firm's extracorporeal treatment is applicable for hard-to-cure blood-borne and neurologic diseases, such as post-traumatic stress disorder (PTSD) and Alzheimer's disease. The company is also developing treatment for coronavirus disease of 2019 (Covid-19), obesity, such as high blood pressure, diabetes, heart disease, stroke, and cancer.
See Also
What is Halberd Corp's Total Equity?
Total Equity
-207.1k
USD
Based on the financial report for Jul 31, 2012, Halberd Corp's Total Equity amounts to -207.1k USD.
What is Halberd Corp's Total Equity growth rate?
Total Equity CAGR 3Y
30%
Over the last year, the Total Equity growth was 52%. The average annual Total Equity growth rates for Halberd Corp have been 30% over the past three years .
